Study Conduct

Study: 65% of pharma and biotech invest in patient-centric initiatives

Wednesday, November 2, 2016

DIA, a professional community and knowledge exchange for global healthcare product development, announced results of its Study of Patient-Centric Initiatives in Drug Development, reporting that the majority of pharmaceutical and biotech companies surveys have adopted patient-centric initiatives in drug development.

[Read More]

Study shows that almost half of pediatric trials are not finished or published

Tuesday, November 1, 2016

As Research Practitioner highlighted earlier this year, clinical research results have been disclosed late or not at all at least 95% of the time since reporting of results from human studies to the federal government’s ClinicalTrials.gov database became mandatory in 2008.1  Most of these trials, however, use adult subjects. Researchers at Boston’s Children Hospital in Massachusetts decided to examine the reporting of pediatric study results and found that almost half of the studies had been discontinued or not published.

[Read More]

Ebola-affected countries receive NIH support research training support

Monday, October 31, 2016

The recent Ebola epidemic in West Africa highlighted the need for better global preparedness and response to disease outbreaks. To help address that need in Guinea, Liberia and Sierra Leone—the countries most affected by the epidemic—the NIH has established a new program to strengthen the research capacity to study Ebola, Lassa fever, yellow fever and other emerging viral diseases. In the initiative’s first funding round, NIH’s Fogarty International Center is awarding grants to four U.S. institutions that will partner with West African academic centers to design training programs for their scientists and health researchers.

[Read More]

Three Questions: Greg Sweatt, ePatientFinder

Monday, October 31, 2016

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Suz Redfearn spoke with Greg Sweatt, co-founder and senior vice president of life sciences for ePatientFinder, a service that CROs and sponsors contract with to help those doctors close to sites mine their patient base for clinical trial subjects.

[Read More]

inVentiv Health launches two global site advisory groups

Monday, October 24, 2016

inVentiv Health, a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market, today announced the launch of two global Site Advisory Groups (SAGs). These activities are part of the company’s commitment to enhanced collaboration with investigative sites, who are essential partners in trial success.

[Read More]

Science 37 to expand clinical trial access to anyone, anywhere, anytime

Monday, October 24, 2016

Science 37, a technology-enabled clinical research company, has completed a $31 million Series B financing. Science 37 is reimagining clinical research by bringing clinical trials to people’s homes, which unlocks access to those beyond a geographical barrier. The investment will help the company grow operations, further develop its novel technology platform and continue to expand into new therapeutic areas.

[Read More]